Skip to main content
. 2021 Feb 6;9(3):e14693. doi: 10.14814/phy2.14693

TABLE 1.

Patient demographics and clinical characteristics per (sub)phenotype

Cluster subphenotypes LCA subphenotypes Etiology phenotype
Uninflamed Reactive p‐value Hypo‐inflammatory Hyper‐inflammatory p‐value Indirect Direct p‐value
n = 11 n = 15 n = 10 n = 16 n = 9 n = 17
Age in years (mean (±SD)) 58 (13) 62 (13) 0.50 61 (14) 60 (12) 0.92 59 (12) 61 (13.6) 0.65
Female (n (%)) 5 (45.5) 8 (53.3) 1.00 3 (30.0) 10 (62.5) 0.23 6 (66.7) 7 (41.2) 0.41
APACHE IV (mean (±SD)) 82 (24.3) 97 (29.8) 0.18 80 (22.2) 98 (30.1) 0.13 93 (33.6) 89.5 (25.9) 0.75
SOFA score at day 1 (mean (±SD)) 7 (2.8) 11 (2.9) 0.007 7.4 (3.1) 10.4 (2.8) 0.02 10.6 (3.1) 8.6 (3.2) 0.15
ARDS risk factor (n (%))
Pneumonia 8 (72.7) 8 (53.3) 0.43 8 (80.0) 8 (50.0) 0.22 0 (0.0) 16 (94.1) <0.001
Aspiration 1 (9.1) 1 (6.7) 1.00 1 (10.0) 1 (6.2) 1.00 0 (0.0) 2 (11.8) 0.53
Sepsis 8 (72.7) 14 (93.3) 0.28 7 (70.0) 15 (93.8) 0.26 7 (77.8) 15 (88.2) 0.59
Trauma 2 (18.2) 0 (0.0) 0.17 2 (20.0) 0 (0.0) 0.14 1 (11.1) 1 (5.9) 1.00
Pancreatitis 0 (0.0) 1 (6.7) 1.00 0 (0.0) 1 (6.2) 1.00 1 (11.1) 0 (0.0) 0.35
Other 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
ARDS severity a (n (%))
Mild 6 (54.5) 2 (13.3) 0.06 6 (60.0) 2 (12.5) 0.03 3 (33.3) 5 (29.4) 0.56
Moderate 4 (36.4) 12 (80.0) 4 (40.0) 12 (75.0) 6 (66.7) 10 (58.8)
Severe 1 (9.1) 1 (6.7) 0 (0.0) 2 (12.5) 0 (0.0) 2 (11.8)
Ventilator‐free days (median (IQR)) 24.0 (3.5, 25.5) 19.0 (7.5, 21.5) 0.19 24.5 (1.8, 25.8) 19.5 (11.3, 22.3) 0.29 21.0 (17,0, 24.0) 19.0 (0.0, 25.0) 0.70
ICU length of stay (median (IQR)) 6.0 (3.5, 11.0) 8.0 (6.5, 12.0) 0.48 6.5 (4.5, 8.8) 8.5 (5.3, 14.0) 0.46 9.0 (6.0, 14.0) 7.0 (4.0, 10.0) 0.48
30‐day survival (n (%)) 8 (72.7) 9 (60.0) 0.68 7 (70.0) 10 (62.5) 1.00 6 (66.7) 11 (64.7) 1.00

Abbreviations: APACHE IV, Acute Physiology and Chronic Health Evaluation score IV; ARDS, acute respiratory distress syndrome; SOFA, Sequential Organ Failure Assessment Score on day 1.

a

Based on the Berlin criteria.